INS and fatty liver disease: Hepatic steatosis level after the MD was reduced in comparison to the LF/HCD and insulin sensitivity improved after the MD with a significant improvement in homeostatic model assessment for insulin resistance (HOMA-IR), but not in peripheral insulin resistance, measured by the glucose infusion rate (GINF) [126].